Filter News
Area of Research
News Type
News Topics
- (-) Artificial Intelligence (1)
- 3-D Printing/Advanced Manufacturing (2)
- Big Data (1)
- Bioenergy (10)
- Biology (18)
- Biomedical (4)
- Biotechnology (4)
- Chemical Sciences (1)
- Clean Water (5)
- Climate Change (5)
- Composites (1)
- Computer Science (3)
- Decarbonization (1)
- Energy Storage (1)
- Environment (24)
- Exascale Computing (1)
- Fusion (1)
- High-Performance Computing (5)
- Materials (3)
- Materials Science (1)
- Mercury (3)
- Microscopy (1)
- Nanotechnology (1)
- Neutron Science (1)
- Polymers (1)
- Security (1)
- Summit (2)
- Sustainable Energy (8)
Media Contacts
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.